SNN — Smith & Nephew SNATS Inc. stock price and chart

SNN

Smith & Nephew SNATS Inc.Stock · Health Care

$29.27-0.1%

as of Aug 27, 1:50 PM ET

PeersLLYMRNAUNHJNJMRKABBV

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDD

20162019202120242026

25.030.035.040.045.050.0010.0M20.0M$29.27

2026-08-27

Price$29.27

MA20$30.73

MA50$32.88

Vol6.9M

What would $1,000 invested in SNN be worth today? →

SNN returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $29.27
Change YTD: -9.44%
Market cap: 12.8B2016-09 29.5B2026-08 12.9B-56.4% over the window
Enterprise value: 12.4B
Shares outstanding: 438.9M2015-12 449.5M2025-12 438.9M-2.4% over the window
52W low: $28.56
52W high: $38.79
From 52W high: -24.47%
From 52W low: +2.49%
52W range: 7%
Beta: 0.55

Volume

Rel volume: 0.05×
30D volume: 1.5M
30D $ vol: 46.6M

Fundamentals

Sales (ttm): 6.2B2015-12 4.6B2025-12 6.2B+33.0% over the window
Sales/share: $14.052015-12 $10.312025-12 $14.05+36.2% over the window
EPS (ttm): $1.432015-12 $0.912025-12 $1.43+57.0% over the window
FCF (ttm): 1.3B
FCF/share: $2.93
Book value/share: $12.052015-12 $8.822025-12 $12.05+36.6% over the window
Net margin: 10.14%2015-12 8.8%2025-12 10.1%+14.6% over the window
ROE: 11.82%2015-12 10.3%2025-12 11.8%+14.3% over the window
ROA: 5.98%2015-12 5.7%2025-12 6.0%+4.5% over the window
Current ratio: 2.572016-12 1.882025-12 2.57+37.1% over the window

Growth (CAGR, ttm) · 10Y

Sales: +6.10%2024-12-31 → 2025-12-315.8B → 6.2B (+6.1% total)+5.73%2022-12-31 → 2025-12-315.2B → 6.2B (+18.2% total)+6.21%2020-12-31 → 2025-12-314.6B → 6.2B (+35.2% total)+2.89%2015-12-31 → 2025-12-314.6B → 6.2B (+33.0% total)
Net income: +51.74%2024-12-31 → 2025-12-31412M → 625M (+51.7% total)+40.98%2022-12-31 → 2025-12-31223M → 625M (+180.3% total)+6.89%2020-12-31 → 2025-12-31448M → 625M (+39.5% total)+4.31%2015-12-31 → 2025-12-31410M → 625M (+52.4% total)
Shares: +0.00%2024-12-31 → 2025-12-31438.9M → 438.9M (+0.0% total)+0.00%2022-12-31 → 2025-12-31438.8M → 438.9M (+0.0% total)-0.16%2020-12-31 → 2025-12-31442.4M → 438.9M (-0.8% total)-0.24%2015-12-31 → 2025-12-31449.5M → 438.9M (-2.4% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +52.38%2024-12-31 → 2025-12-31$0.94 → $1.43 (+52.3% total)+41.07%2022-12-31 → 2025-12-31$0.51 → $1.43 (+180.8% total)+6.94%2020-12-31 → 2025-12-31$1.02 → $1.43 (+39.8% total)+4.61%2015-12-31 → 2025-12-31$0.91 → $1.43 (+57.0% total)
Sales/share: +6.09%2024-12-31 → 2025-12-31$13.24 → $14.05 (+6.1% total)+5.73%2022-12-31 → 2025-12-31$11.88 → $14.05 (+18.2% total)+6.39%2020-12-31 → 2025-12-31$10.31 → $14.05 (+36.3% total)+3.14%2015-12-31 → 2025-12-31$10.31 → $14.05 (+36.2% total)
Book value/share: +0.45%2024-12-31 → 2025-12-31$12.00 → $12.05 (+0.5% total)+0.19%2022-12-31 → 2025-12-31$11.98 → $12.05 (+0.6% total)+0.20%2020-12-31 → 2025-12-31$11.93 → $12.05 (+1.0% total)+3.17%2015-12-31 → 2025-12-31$8.82 → $12.05 (+36.6% total)
Dividend/share: +0.92%2024-12-31 → 2025-12-31$0.75 → $0.75 (+0.9% total)+0.30%2022-12-31 → 2025-12-31$0.75 → $0.75 (+0.9% total)+0.28%2020-12-31 → 2025-12-31$0.74 → $0.75 (+1.4% total)+2.20%2015-12-31 → 2025-12-31$0.61 → $0.75 (+24.3% total)
Price: -21.44%2025-08-27 → 2026-08-27$37.25 → $29.27 (-21.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+2.95%2023-08-28 → 2026-08-27$26.83 → $29.27 (+9.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-5.35%2021-08-27 → 2026-08-27$38.54 → $29.27 (-24.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-1.19%2016-08-26 → 2026-08-27$32.98 → $29.27 (-11.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -19.58%2025-08-27 → 2026-08-27$36.39 → $29.27 (-19.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+5.73%2023-08-28 → 2026-08-27$24.77 → $29.27 (+18.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-2.82%2021-08-27 → 2026-08-27$33.78 → $29.27 (-13.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+1.10%2016-08-26 → 2026-08-27$26.25 → $29.27 (+11.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains.: 20.4×2016-09 71.882026-08 20.58-71.4% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 16.2×2016-09 46.932026-08 16.20-65.5% over the window
Fwd P/E: 12.0×
P/S (ttm)Market cap ÷ TTM revenue.: 2.1×2016-09 6.362026-08 2.09-67.2% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 2.4×2016-09 7.432026-08 2.43-67.3% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 10.0×
EV/EBITDA (fy): 10.1×
EV/Sales (ttm): 2.0×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 10.00%
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 2.57%
Dividend/share (fwd): $0.75
Buyback yield (realized, 1y)1 − shares_at(2025-12-31) ÷ shares_at(2024-12-31) = 1 − 438.9M ÷ 438.9M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -0.00%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-0.00%) + dividends paid over that year ($330M) ÷ market_cap_at(2024-12-31) ($21.6B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 1.53%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($502M) ÷ today's market cap ($12.8B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 3.91%2016-12 1.3%2025-12 1.7%+31.7% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $502M + TTM dividends $330M) ÷ today's market cap ($12.8B). Same caveat as the cash buyback yield.: 6.48%2016-12 2.4%2025-12 2.9%+22.6% over the window

Vs own 10Y history

P/E: 0th
P/OI: 0th
P/S: 0th
P/B: 0th

Bar = where today’s multiple sits in SNN’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-08-26

-0.10%

-0.14%

-10.10%

-3.11%

YTD

-9.44%

-19.35%

-12.43%

Financial statements

Open full SNN financials →

Loading financial statements…

Ticker	Name	1M	1D
NVS	Novartis AG	-3.15%	-1.73%
NVO	Novo Nordisk A/S	-8.03%	-1.94%
SNY	Sanofi ADS	-1.39%	-1.12%
GSK	GSK plc American Depositary Shares (Each representing two Ordinary Shares)	-5.43%	-2.13%
ARGX	argenx SE American Depositary Shares	+21.11%	+0.90%
TAK	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	+3.25%	-0.85%
NTRA	Natera Inc.	+34.87%	+0.46%
RVMD	Revolution Medicines Inc.	+19.19%	+1.84%

Smith & Nephew SNATS Inc. (SNN) trades at $29.27 with a live price and an interactive chart covering 26+ years of daily price history, plus key valuation metrics. ChartRow also publishes SNN’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full SNN financial statements →

SNN — Smith & Nephew SNATS Inc. price, chart and key statistics